A
Aerovate Therapeutics
AVTE
1.79000
USD
-0.02
(-1.11%)
مغلق
حجم التداول
81,767
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
80,540,914
العنوان: Aerovate Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powderinhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.